Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACTIC-TAVI: Ticagrelor Dose and Platelet Reactivity After TAVI
2019-004860-23Phase 4Completed
- Sponsor
- Andres Iñiguez Romo
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ticagrelor in aortic stenosis (AS) (2 arms), sponsored by Andres Iñiguez Romo. Primary endpoint: High platelet reactivity suppression with ticagrelor. Started Mar 2020; status: completed.
02
Drugs
ticagrelor
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2019-004860-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004860-23.